D1 Capital Partners L.P. Grows Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

D1 Capital Partners L.P. grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 22.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,486,584 shares of the company's stock after purchasing an additional 629,270 shares during the quarter. GE HealthCare Technologies comprises about 4.5% of D1 Capital Partners L.P.'s investment portfolio, making the stock its 7th biggest position. D1 Capital Partners L.P. owned approximately 0.76% of GE HealthCare Technologies worth $272,581,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Cherry Creek Investment Advisors Inc. raised its holdings in shares of GE HealthCare Technologies by 0.3% during the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company's stock valued at $2,920,000 after purchasing an additional 114 shares in the last quarter. Independence Bank of Kentucky raised its holdings in GE HealthCare Technologies by 6.0% in the 4th quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock worth $158,000 after acquiring an additional 114 shares during the period. Haverford Trust Co lifted its position in GE HealthCare Technologies by 2.4% during the 4th quarter. Haverford Trust Co now owns 4,896 shares of the company's stock worth $383,000 after acquiring an additional 115 shares during the last quarter. Tandem Capital Management Corp ADV grew its position in shares of GE HealthCare Technologies by 0.4% in the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock valued at $2,205,000 after purchasing an additional 118 shares during the last quarter. Finally, Arcus Capital Partners LLC increased its stake in shares of GE HealthCare Technologies by 3.0% in the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock worth $322,000 after purchasing an additional 119 shares during the period. Institutional investors own 82.06% of the company's stock.

Analysts Set New Price Targets

Several research firms recently weighed in on GEHC. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Citigroup boosted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. BTIG Research set a $95.00 price objective on GE HealthCare Technologies and gave the stock a "buy" rating in a research report on Monday, April 14th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and an average target price of $96.50.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock traded down $0.42 during trading hours on Tuesday, hitting $67.65. The stock had a trading volume of 2,842,662 shares, compared to its average volume of 3,265,538. The company has a 50-day moving average of $76.10 and a two-hundred day moving average of $81.91. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market cap of $30.97 billion, a PE ratio of 15.64, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.21%. GE HealthCare Technologies's dividend payout ratio is currently 3.23%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.